<SEC-DOCUMENT>0001144204-17-011681.txt : 20170228
<SEC-HEADER>0001144204-17-011681.hdr.sgml : 20170228
<ACCEPTANCE-DATETIME>20170228160527
ACCESSION NUMBER:		0001144204-17-011681
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170227
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170228
DATE AS OF CHANGE:		20170228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVAVAX INC
		CENTRAL INDEX KEY:			0001000694
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				222816046
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26770
		FILM NUMBER:		17647588

	BUSINESS ADDRESS:	
		STREET 1:		20 FIRSTFIELD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
		BUSINESS PHONE:		240-268-2000

	MAIL ADDRESS:	
		STREET 1:		20 FIRSTFIELD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v460682_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C.&nbsp;20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; padding-top: 5.4pt"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION&nbsp;13 OR 15(d)
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of Report (Date of earliest event
reported): February 27, 2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOVAVAX, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified
in charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; text-align: center; width: 32%"><B>Delaware</B></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 32%"><B>0-26770</B></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 32%"><B>22-2816046</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or Other Jurisdiction</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of Incorporation)&nbsp;</B></P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Commission File Number)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(I.R.S. Employer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification No.)&nbsp;</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>20 Firstfield Road</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gaithersburg, Maryland 20878</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of Principal Executive Offices,
including Zip Code) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(240) 268-2000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Registrant&rsquo;s telephone number,
including area code) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>(Former name or former
address, if changed since last report.) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 35%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Item 2.02. Results of Operations and Financial
Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>Fourth Quarter Financial Results</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On February 27,
2017, Novavax, Inc. (the &ldquo;Company&rdquo;) issued a press release announcing the Company&rsquo;s financial results for the
quarter ended December 31, 2016. A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information
in Items 2.02 and 9.01 of this Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for purposes of Section
18 of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act except as expressly
set forth by specific reference in such a filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Item 9.01. Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; background-color: white">Press release, dated February 27, 2017, regarding the Company&rsquo;s financial results for the quarter ended </FONT><FONT STYLE="font-size: 10pt">December 31, 2016<FONT STYLE="background-color: white">.</FONT></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.5in; text-indent: -0.5in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Novavax, Inc.</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.5in; text-indent: -0.5in">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: February 28, 2017</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ John A. Herrmann III</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John A. Herrmann III</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice President, General Counsel and Corporate Secretary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt; background-color: white">Press release, dated February 27, 2017, regarding the Company&rsquo;s financial results for the quarter ended </FONT><FONT STYLE="font-size: 10pt">December 31, 2016<FONT STYLE="background-color: white">.</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v460682_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 30.75pt; width: 198pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Novavax Reports Fourth Quarter and Year-End
2016 Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Gaithersburg,
MD, February 27, 2017 &ndash; Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the fourth quarter and twelve
months ended December 31, 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Recent
and Fourth Quarter Achievements:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Continued execution
of the global Phase 3 Prepare&trade; clinical trial to prevent RSV in infants via maternal immunization. Prepare is a randomized,
observer-blinded, placebo-controlled trial, conducted at multiple international sites. The primary objective is to determine the
efficacy of maternal immunization with our RSV F Vaccine against symptomatic RSV lower respiratory tract infection with hypoxemia
in infants through a minimum of the first 90 days of life.&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepare
is supported by <FONT STYLE="background-color: white">a grant of up to&nbsp;</FONT>$89 million<FONT STYLE="background-color: white">&nbsp;from
the&nbsp;</FONT>Bill &amp; Melinda Gates Foundation (BMGF)<FONT STYLE="background-color: white">; and</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Initiation of
a randomized, observer-blinded, multi-arm, dose-ranging Phase 2 clinical trial, in one and two dose formulations, both with and
without adjuvants, of the RSV F Vaccine in older adults (60 years of age and older). The trial will evaluate safety and immunogenicity
of these formulations in older adults as measured by serum microneutralization titers against RSV/A and RSV/B, palivizumab competing
antibodies (PCA) and anti-F IgG.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">&ldquo;We&rsquo;ve made
significant progress executing on the path forward that we outlined in late 2016,&rdquo; said Stanley C. Erck, President and CEO.
&ldquo;For the remainder of the year we will focus on the ongoing Phase 3 trial of our RSV F Vaccine for infants via maternal immunization
and on understanding the results of our Phase 2 immunogenicity trial in older adults, along with a deeper understanding of the
Resolve Phase 3 trial results we reported last September. We also plan on moving our Zika and nanoparticle influenza vaccine programs
into the clinic later this year.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Financial
Results for the Three and Twelve Months Ended December 31, 2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Novavax
reported a net loss of $57.1 million, or $0.21 per share, for the fourth quarter of 2016, compared to a net loss of $78.8 million,
or $0.29 per share, for the fourth quarter of 2015. For the twelve months ended December 31, 2016, the net loss was $280.0 million,
or $1.03 per share, compared to a net loss of $156.9 million, or $0.60 per share, for the same period in 2015. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Novavax
revenue in the fourth quarter of 2016 decreased 8% to $5.4 million, compared to $5.9 million for the same period in 2015. Revenue
for the full year 2016 decreased 58% to $15.4 million, compared to $36.3 million in 2015. The decrease in revenue under the HHS
BARDA contract in 2016 of approximately $31 million relative to 2015 accounts for the decrease. The lower HHS BARDA revenue is
the result of a lower level of activity, primarily resulting from the natural expiration of the BARDA contract, as compared to
the same period in 2015. This decrease in HHS BARDA revenue was partially offset by an increase of $9.4 million in revenue in 2016
recorded under the BMGF grant relating to our ongoing Prepare clinical trial. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Research
and development expenses decreased 33% to $51.1 million in the fourth quarter of 2016, compared to $75.9 million for the same period
in 2015. For the full year 2016, research and development expenses increased 46% to $237.9 million, compared to $162.6 million
in 2015. The increase in research and development expenses for the full year 2016 was primarily due to increased costs associated
</FONT>with the clinical trials and development activities of our RSV F Vaccine and higher employee-related costs, <FONT STYLE="background-color: white">including
non-cash stock-based compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">General
and administrative expenses decreased 6% to $8.3 million in the fourth quarter of 2016, compared to $8.9 million for the same period
in 2015. For the full year 2016, general and administrative expenses increased 51% to $46.5 million, compared to $30.8 million
in 2015. The increase was primarily due to higher employee-related costs and professional fees for pre-commercialization activities
as compared to the same period in 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Interest
income (expense), net for the fourth quarter and full year 2016 includes $3.4 million and $12.5 million, respectively, of interest
expense relating the Company&rsquo;s Convertible Senior Notes offering in the first quarter of 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">As
of December 30, 2016, the company had $235.5 million in cash and cash equivalents and marketable securities compared to $230.7
million as of December 31, 2015. Net cash used in operating activities for the full year 2016 was $255.5 million, compared to $126.1
million for same period in 2015. The increase in cash usage was primarily due to increased costs relating to our RSV F Vaccine
and higher employee-related costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Conference
Call</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Novavax
management will host its quarterly conference call today at 4:30 p.m. ET. The dial-in number for the conference call is </FONT>(877)
212-9076 <FONT STYLE="background-color: white">(Domestic) or </FONT>(707) 287-9331 <FONT STYLE="background-color: white">(International),
passcode </FONT>61206704<FONT STYLE="background-color: white">. A replay of the conference call will be available starting at 7:30
p.m. on February 27, 2017 until midnight March 3, 2017. To access the replay by telephone, dial (855) 859-2056 (Domestic) or (404)
537-3406 (International) and use passcode </FONT>61206704<FONT STYLE="background-color: white">. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">A
webcast of the conference call can also be accessed via a link on the home page of the Novavax website (novavax.com) or through
the &quot;Investor Info&quot;/&quot;Events&quot; tab on the Novavax website. A replay of the webcast will be available through
the &quot;Investor Info&quot;/&quot;Events&quot; tab on the Novavax website until April 30, 2017. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Novavax</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant
nanoparticles and Matrix-M&trade; adjuvant technology are the foundation for groundbreaking innovation that improves global health
through safe and effective vaccines. Additional information about Novavax is available on the Company's website, <FONT STYLE="color: Blue"><U>novavax.com</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Statements herein relating to the future
of Novavax and the ongoing development of its vaccine and adjuvant products are forward-looking statements. Novavax cautions that
these forward looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially
from those expressed or implied by such statements. These risks and uncertainties include those identified under the heading &ldquo;Risk
Factors&rdquo; in the Novavax Annual Report on Form 10-K for the year ended December 31, 2016 to be filed with the Securities and
Exchange Commission (SEC). We caution investors not to place considerable reliance on the forward-looking statements contained
in this press release. You are encouraged to read our filings with the SEC, available at sec.gov, for a discussion of these and
other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document,
and we undertake no obligation to update or revise any of the statements. Our business is subject to substantial risks and uncertainties,
including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and
uncertainties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">###</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOVAVAX, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(in thousands, except per share information)</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Three Months Ended</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Twelve Months Ended</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">December 31,</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">December 31,</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Revenue</TD><TD STYLE="width: 2%; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,399</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,853</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">15,353</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">36,250</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25in">Research and development</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">51,100</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">75,903</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">237,939</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">162,644</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.25in">General and administrative</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">8,344</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,852</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">46,527</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">30,842</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.375in">Total expenses</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">59,444</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">84,755</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">284,466</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">193,486</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from operations</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(54,045</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(78,902</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(269,113</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(157,236</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest income (expense), net</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(3,066</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">95</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(10,822</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">419</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other income (expense)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(31</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(120</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(57,109</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(78,806</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(279,966</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(156,937</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(0.21</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.29</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(1.03</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.60</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted weighted average number of common shares outstanding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">271,200</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">269,863</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">270,802</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">262,248</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELECTED BALANCE SHEET DATA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(in thousands)</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 72%; font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: bold 10pt Times New Roman, Times, Serif; text-align: right">144,353</TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">93,108</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Marketable securities</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">91,126</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">137,548</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current assets</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">287,830</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">287,257</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Working capital</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">221,424</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">210,763</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total assets</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">394,301</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">386,038</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total notes payable and capital lease obligation</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">316,376</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">503</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total stockholders&rsquo; equity (deficit)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(5,546</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">292,669</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contact: &#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Investor Relations</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Novavax, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Andrea N. Flynn, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Associate Director, Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: blue"><U>ir@novavax.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">240-268-2000</P>

<P STYLE="font: 10pt Courier; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Courier; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Westwicke Partners&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John Woolford&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Blue"><U>john.woolford@westwicke.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">443-213-0506</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Media</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Russo Partners, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">David Schull</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Todd Davenport, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Blue"><U>david.schull@russopartnersllc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">212-845-4271</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !> ET# 2(  A$! Q$!_\0
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MZ\_(.F":_/G_ (*/_P#!3KQE^W_\0)XYY;C1? .GSL=)T&.3"8'2:?&/,E.
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M_1-JWEH?6W@S_@KI^UG\1?%NFZ#H?Q'UG4]8UBY2TL[6#2K)Y)Y7.%4#R?\
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MOV['8JEA,/.O/X8J_P#DOGLC\<P.%J8JO&A'>3_X=_J?1O[1_P#P2!7X<?\
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M?\&O'_'C\7_^NFF?RN*^>XQ_Y%-7Y?\ I2/>X2_Y&=/Y_D?K5.,IQZU_.O\
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MG%D_-CC<Q9B.]>/YK]+X9X9_LV#J56G4EIIT7;_,_/>(^(?[0DJ=)-0B^N[
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M'Q'_ ,%,?^",OA/]N43^)]!EM_"/Q'2+:-0"?Z+JN  JW2 9R ,"1?F&>0P
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M?"0H8F,G*.EU9Z=-VNFA^?YMP?5Q&+E5H245+6SOOUV/YSLXI"P_7%?T9_\
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MX$^V"BBB@!K('&"-WUK\5_\ @Y$_8^'@/XQZ+\7M'M@NG^,%73=:*+A8[V%
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MX9_;9^!6D^-O#4VU;I!#J%D[ S:;=!1YD#C/4$\'HP((ZU_+[7TE_P $Q_\
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8RDMK^?KW/T#A'/7;ZEB&VEL^OI_D?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
